Healthbeat - Your Source for Daily Health Trends and Medical News

STAT+: Live updates: Marty Makary, Trump’s pick for FDA commissioner, testifies before Senate panel

Marty Makary, Trump’s pick for FDA commissioner, testifies before a Senate panel this morning. Follow STAT's live updates.

How nanoplastics are invading our bodies – video

Plastics are everywhere, but their smallest fragments – nanoplastics – are making their way into the deepest parts of our bodies, including our brains and breast milk.

Stephen Powis to step down as NHS England medical director

Powis, who had a key role in advising ministers and public during pandemic, follows chief executive in resigningUK politics live – latest updatesThe NHS’s top doctor in England, who played a key r

F.D.A. Nominee to Face Grilling Over Cutbacks and Policy Shifts

Dr. Marty Makary will testify before the Senate health committee on Thursday. Lawmakers may press him over staff reductions and changes in agency direction on issues like vaccines.

Clearing the Way for Bicyclists, for a Healthier Planet

Jill Warren heads the European Cyclists’ Federation, a Brussels-based nongovernmental organization that advocates cycling to help lower carbon emissions.

Digging Out of a Therapy Rut

Here’s how to know, and how to get out of it.

For Seniors With Hoarding Disorder, a Support Group Helps Confront Stigma and Isolation

Hoarding disorder disproportionately affects older people. As baby boomers age, it is a growing public health concern.

To Patients, Parents, and Caregivers, Proposed Medicaid Cuts Are a Personal Affront

At a town hall in Orange County, California, angry residents said Congress should keep its hands off Medicaid.

‘Get in Dorks’: Stand Up for Science rallies spread to 32 U.S. cities

Frustrated that there seemed to be no large-scale pro-science movement coalescing, a graduate student took matters into her own hands

STAT+: New radiopharmaceutical heading to the FDA after Phase 3 win

ITM, a pioneer in radiopharmaceuticals, said it will submit its first drug for approval after reporting the therapy halted tumor progression for nearly two years.

All News